StockData
BGMNasdaqPharmaceutical PreparationsFiscal year ends September 30

BGM Group Ltd.

Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 20-F on Jul 21, 2026
$8.97+0.32 (+3.70%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

About BGM

Pharmaceutical Preparations, SIC 2834

BGM Group Ltd is a holding company that conducts its business activities in China through contractual variable interest entity arrangements. The operating business primarily develops, manufactures, markets, and sells traditional Chinese medicine products and pieces, alongside operating a sausage casings business. Additionally, its enterprise network encompasses technology services, management consulting, and electronic commerce services. The group directs its offerings to consumers and commercial purchasers in the healthcare, pharmaceutical, food processing, and related commercial markets.

The company operates primarily across the People's Republic of China, maintaining functional subsidiaries and facilities in locations such as Jiuquan in Gansu Province, Chengdu and Sichuan Province, Jiangsu Province, Hainan, Shenzhen, and Beijing, with overseas corporate entities organized in Hong Kong and the British Virgin Islands. BGM Group Ltd maintains its corporate holding company headquarters and legal incorporation in the Cayman Islands.

Summary of the business section of BGM's latest annual report, written by StockData.

Company profile

Company

Legal name
BGM Group Ltd.
Founded
1969
Headquarters
Chengdu, China
Address
No. 152 Hongliang East 1st Street, No. 1703, Tianfu New District 0000
Phone
86-028-64775180
Employees
206, Sep 30, 2025
Industry
Pharmaceutical Preparations
Incorporated in
E9
Fiscal year ends
September 30
Auditor
ZH CPA, LLC, Denver, Colorado

Stock & identifiers

Ticker
BGM
Exchange
Nasdaq
IPO date
Jan 12, 2021
Shares outstanding
401M, Sep 30, 2025
Filer category
Non-accelerated filer<br>Emerging growth company
Stock splits
1-for-30 reverse, Oct 1, 2026; 1-for-5 reverse, Jun 21, 2024; 1-for-5 reverse, Jun 21, 2024
SEC CIK
1779578
CUSIP
G7307E123
ISIN
USG7307E1233
EIN
00-0000000

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Yaxuan ZHAIChief Financial Officer–
yuehua renDirector–
Waihua XuDirector–
Zefei LouDirector–
LIN (Henry) ZHANGDirector–

Employees

Headcount reported in annual reports

“The following table sets forth a breakdown of employees by activity in Jiuquan City and Qionglai City for Gansu QLS, Moshangfa and Chengdu QLS as of September 30, 2025: … Total 206”

Corporate history

Events identified from SEC filings

DateEventDetails
Jan 30, 2026Late filingNotification of late filing
Oct 22, 2024Name changeName changed from Qilian International Holding Group to BGM Group Ltd.
Oct 16, 2024Name changeName changed from Qilian International Holding Group Ltd to Qilian International Holding Group
Feb 1, 2024Late filingNotification of late filing
Jan 31, 2023Late filingNotification of late filing
Jan 31, 2022Late filingNotification of late filing
Jan 12, 2021IPOInitial public offering priced (424B4 prospectus)
Dec 14, 2020ListingRegistration of securities on an exchange (Form 8-A)